These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27611645)

  • 21. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
    Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
    J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical insight into the emergence of influenza virus strains that are resistant to Relenza.
    Shidmoossavee FS; Watson JN; Bennet AJ
    J Am Chem Soc; 2013 Sep; 135(36):13254-7. PubMed ID: 24001125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
    Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
    J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combined effective fragment potential-fragment molecular orbital method. I. The energy expression and initial applications.
    Nagata T; Fedorov DG; Kitaura K; Gordon MS
    J Chem Phys; 2009 Jul; 131(2):024101. PubMed ID: 19603964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
    Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
    Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragment Molecular Orbital Calculations with Implicit Solvent Based on the Poisson-Boltzmann Equation: II. Protein and Its Ligand-Binding System Studies.
    Okiyama Y; Watanabe C; Fukuzawa K; Mochizuki Y; Nakano T; Tanaka S
    J Phys Chem B; 2019 Feb; 123(5):957-973. PubMed ID: 30532968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 Neuraminidase.
    Prachanronarong KL; Özen A; Thayer KM; Yilmaz LS; Zeldovich KB; Bolon DN; Kowalik TF; Jensen JD; Finberg RW; Wang JP; Kurt-Yilmaz N; Schiffer CA
    J Chem Theory Comput; 2016 Dec; 12(12):6098-6108. PubMed ID: 27951676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
    Ferraris O; Kessler N; Lina B
    Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydration Thermodynamics of Non-Polar Aromatic Hydrocarbons: Comparison of Implicit and Explicit Solvation Models.
    Lee H; Lim HK; Kim H
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30423973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach.
    Mai BK; Li MS
    Biochem Biophys Res Commun; 2011 Jul; 410(3):688-91. PubMed ID: 21693105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir.
    Somasundaram B; Fee CJ; Fredericks R; Watson AJ; Fairbanks AJ; Hall RJ
    J Mol Recognit; 2015 Sep; 28(9):521-7. PubMed ID: 25727669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-ligand binding affinity predictions by implicit solvent simulations: a tool for lead optimization?
    Michel J; Verdonk ML; Essex JW
    J Med Chem; 2006 Dec; 49(25):7427-39. PubMed ID: 17149872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taking Water into Account with the Fragment Molecular Orbital Method.
    Okiyama Y; Fukuzawa K; Komeiji Y; Tanaka S
    Methods Mol Biol; 2020; 2114():105-122. PubMed ID: 32016889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fragment quantum mechanical calculation of proteins and its applications.
    He X; Zhu T; Wang X; Liu J; Zhang JZ
    Acc Chem Res; 2014 Sep; 47(9):2748-57. PubMed ID: 24851673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Fragmenting Protocol with Explicit Hydration for Calculation of Binding Enthalpies of Target-Ligand Complexes at a Quantum Mechanical Level.
    Horváth I; Jeszenői N; Bálint M; Paragi G; Hetényi C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 37. Exploring Strong Interactions in Proteins with Quantum Chemistry and Examples of Their Applications in Drug Design.
    Xie NZ; Du QS; Li JX; Huang RB
    PLoS One; 2015; 10(9):e0137113. PubMed ID: 26339784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
    Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
    J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
    Sauerbrei A; Haertl A; Brandstaedt A; Schmidtke M; Wutzler P
    Med Microbiol Immunol; 2006 Jun; 195(2):65-71. PubMed ID: 16059699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calculations of Solvation Free Energy through Energy Reweighting from Molecular Mechanics to Quantum Mechanics.
    Jia X; Wang M; Shao Y; König G; Brooks BR; Zhang JZ; Mei Y
    J Chem Theory Comput; 2016 Feb; 12(2):499-511. PubMed ID: 26731197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.